US wants to give pharma more power over our medicines policy

Leaked documents from the Trans Pacific Partnership (TPP) Agreement negotiations currently underway in Peru show the US is seeking to use the agreement to increase the monopoly rights of pharmaceutical companies and undermine the effectiveness of pharmaceutical reimbursement programs like Australia’s Pharmaceutical Benefits Scheme.

The TPP is a proposed regional trade agreement involving Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore, the United States and Vietnam.

The texts, leaked over the weekend, include an annex on ‘transparency and procedural fairness for healthcare technologies’ and extra provisions for an intellectual property rights chapter that was leaked in February this year — via

Share this Story
Load More Related Articles
Load More By Red Wolf
Load More In Business

Leave a Reply

Your email address will not be published. Required fields are marked *

Photos from Flickr